Searched for
RAZEL
Intent of global acquisitions, has the tide turned for the long term? 5 pharma stocks with upside potential of up to 31 %Just yesterday, there was a news report which suggested that the French government is planning to block the sale of a French generic drug m...25 Apr, 2024, 04.45 PM IST- Fundamental tailwinds are a stronger play than volatile markets? 5 Indian pharma stocks with upside potential of up to 41%There is no doubt that the market is going through a volatile phase and bears are once again telling the street to never write them off. Wi...23 Mar, 2024, 03.55 PM IST
- Preparing for volatility is better than suffering it: 5 largecap stocks from different sectors with upside scope of up to 22%Last week two noticeable things happened in the market, first a sharp correction in mid-cap stocks and then on Friday sudden sharp recovery...03 Mar, 2024, 05.14 PM IST
- Business and valuation tailwinds to help in outperformance? 5 Indian pharma stocks with upside potential of up to 32%Just before the whole market was consumed by the PSU rally, one sector that came into the limelight after many years of underperformance wa...18 Feb, 2024, 01.21 PM IST
- JB Pharma open to more buys to grow branded biz shareJB Chemicals & Pharmaceuticals (JB Pharma), controlled by US private equity firm KKR, is evaluating assets for acquisitions to strengthen i...24 Nov, 2023, 11.58 PM IST
- JB Pharma Q1 Results: Net profit surges 35% YoY to Rs 142 croreDomestic business revenue grew 17% YoY to Rs 489 crores in Q1FY24, despite sales for the acute business being impacted due to the delayed m...09 Aug, 2023, 07.51 PM IST
- Fantastic 4 multibagger stocks that have given at least 25% return in last 4 years. Will history repeat?Four consistent performers in the Indian stock market have been identified through a screener search, each having delivered over 25% annual...31 May, 2023, 09.55 AM IST
- JB Pharma bets big on chronic therapy for its growth aspirationsJB Chemicals & Pharmaceuticals is keen to explore new opportunities in the world of metabolics and improve its own chronic contribution to ...29 Mar, 2023, 12.00 PM IST
- On a path to recovery; 5 mid-cap pharma stocks with an upside potential up to 41%As the markets get jittery, select pharma stocks are back in focus. This tends to happen in bearish markets. Some of them are mid-sized Ind...22 Mar, 2023, 02.33 PM IST
- On a path to recovery; 7 mid-cap pharma stocks with an upside potential up to 47 %After the covid tailwinds got over, pharma stocks witnessed a phase of under-performance. However as the markets get jittery, select pharma...02 Mar, 2023, 01.04 PM IST
- JB Pharma Q3 Results: Net profit rises 26% to Rs 106 croreThe earnings before interest, tax, depreciation and ammortisation (EBITDA) rose 28% YoY to Rs 193 crore. The EBTIDA margin dropped 120 basi...08 Feb, 2023, 08.45 PM IST
- Defensive Bets: 4 midcaps from pharma sector with ‘Buy’ & ‘Strong Buy’ ratings have upside potential of up to 31%As NIFTY gets even more volatile, there are some sectors which are traditionally considered defensive and they tend to get attention when m...07 Feb, 2023, 02.46 PM IST
- Stocks in the news: Sula Vineyards, RIL, Adani Enterprises, Bandhan Bank and Adani PowerSula Vineyards, India's largest wine producer, will make its debut on the bourses on Thursday. The company had raised a little more than Rs...22 Dec, 2022, 07.30 AM IST
- Hot Stocks: Brokerages on JB Chemicals, Indian Hotels and banksThe global brokerage firm believes that the deposit rate war brewing is on the expected lines and margins will peak out in Q3FY23. HDFC Ban...15 Dec, 2022, 11.19 AM IST
- Stocks in the news: SBI, Wipro, Tata Motors, IRCTC, Power Grid and multiplexesState Bank of India said its board has approved Rs 10,000 crore capital raising plan through Tier I bonds. The fund raising through Additio...15 Dec, 2022, 07.23 AM IST
- JB Pharma acquires cardiac brand from Glenmark for Rs 314 croreJB Pharma on Wednesday said it has acquired cardiac brand Razel (rosuvastatin) for India and Nepal region from Glenmark for Rs 314 crore in...15 Dec, 2022, 12.52 AM IST
- JB Pharma acquires rosuvastatin brand from Glenmark for Rs 314 croreThe acquisition will be funded through long term debt and internal accruals. Razel ranks among the top 10 brands in India in the rosuvastat...14 Dec, 2022, 06.24 PM IST
Load More
